Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 234

    1.

    Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.

    Pearson RD, Hewlett EL.

    Ann Intern Med. 1987 May;106(5):714-8. Review.PMID: 3551713 [PubMed - indexed for MEDLINE]Related articles

    2.

    Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

    Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC.

    Am J Trop Med Hyg. 1986 May;35(3):451-8.PMID: 2939735 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.

    Raviglione MC, Dinan WA, Pablos-Mendez A, Palagiano A, Sabatini MT.

    Arch Intern Med. 1988 Dec;148(12):2683-5.PMID: 3264143 [PubMed - indexed for MEDLINE]Related articles

    4.

    Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.

    [No authors listed]

    JAMA. 1985 Jan 25;253(4):483. No abstract available. PMID: 3881605 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.

    Gottlieb MS, Knight S, Mitsuyasu R, Weisman J, Roth M, Young LS.

    Lancet. 1984 Aug 18;2(8399):398-9. No abstract available. PMID: 6147471 [PubMed - indexed for MEDLINE]Related articles

    6.

    Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.

    Centers for Disease Control (CDC).

    MMWR Morb Mortal Wkly Rep. 1986 Jan 17;35(2):21-22, 27. No abstract available. PMID: 3001495 [PubMed - indexed for MEDLINE]Related articles

    7.

    Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.

    Navin TR, Miller KD, Satriale RF, Lobel HO.

    Lancet. 1985 Jun 8;1(8441):1332. No abstract available. PMID: 2860516 [PubMed - indexed for MEDLINE]Related articles

    8.

    Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.

    Herzog C, Kibbler CC, Ellis CJ, Mtawali CV.

    Br Med J (Clin Res Ed). 1983 Oct 1;287(6397):947-8. No abstract available. PMID: 6412900 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.

    [No authors listed]

    JAMA. 1986 Feb 7;255(5):597. No abstract available. PMID: 3003409 [PubMed - indexed for MEDLINE]Related articles

    10.

    Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.

    Fogh S, Schapira A, Bygbjerg IC, Jepsen S, Mordhorst CH, Kuijlen K, Ravn P, Rønn A, Gøtzsche PC.

    Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):820-2.PMID: 3130927 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.

    Bamber MG, Elder AT, Gray JA, Minns RA.

    J Infect. 1986 Jul;13(1):31-3.PMID: 3734464 [PubMed - indexed for MEDLINE]Related articles

    12.

    Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.

    Hurwitz ES, Johnson D, Campbell CC.

    Lancet. 1981 May 16;1(8229):1068-70.PMID: 6112445 [PubMed - indexed for MEDLINE]Related articles

    13.

    Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.

    Darlow B, Vrbova H, Gibney S, Jolley D, Stace J, Alpers M.

    Am J Trop Med Hyg. 1982 Jan;31(1):1-9.PMID: 7036764 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.

    Fischl MA, Dickinson GM.

    Ann Intern Med. 1986 Oct;105(4):629. No abstract available. PMID: 3489429 [PubMed - indexed for MEDLINE]Related articles

    15.

    Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.

    Eyre SJ.

    Br Med J (Clin Res Ed). 1984 Feb 25;288(6417):644. No abstract available. PMID: 6421416 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.

    Lobel HO, Roberts JM, Somaini B, Steffen R.

    J Infect Dis. 1987 Jun;155(6):1205-9.PMID: 3553347 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.

    Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE.

    Br Med J (Clin Res Ed). 1987 Aug 8;295(6594):365-6. No abstract available. PMID: 2958104 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.

    Kollaritsch H, Stemberger H, Mailer H, Kremsner P, Kollaritsch R, Leimer R, Wiedermann G.

    Trans R Soc Trop Med Hyg. 1988;82(4):524-9.PMID: 2908258 [PubMed - indexed for MEDLINE]Related articles

    19.

    Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.

    Miller KD, Lobel HO, Pappaioanou M, Patchen LC, Churchill FC.

    J Infect Dis. 1986 Oct;154(4):689-91. No abstract available. PMID: 3528321 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data